Large duodenal somatostatinoma in the third portion associated with severe glucose intolerance

Internal Medicine

Volumn 43, Issue 8, 2004, Pages 704-707

  Kimura, Ryosuke ^b   Hayashi, Yoshinari ^b   Takeuchi, Toyo ^b   Shimizu, Manabu ^b   Hiratsuka, Maki ^b   Yoshida, Michihiro ^b   Hamajima, Eiji ^b   Iwata, Masaru ^b   Imoto, Masami ^b   Hattori, Hideo ^a  

^a Kariya General Hospital   (Japan)

^b Toyota Kai Medical Corporation Kariya Toyota General Hospital   (Japan)

Author keywords

Diabetes mellitus; Duodenal somatostatinoma; Endocrine tumor; Insulin; Somatostatin

Indexed keywords

C PEPTIDE; CONTRAST MEDIUM; GLUCOSE; HEMOGLOBIN A1C; INSULIN LISPRO; SOMATOSTATIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DUODENUM TUMOR; GASTROINTESTINAL ENDOSCOPY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INTESTINE SURGERY; LIGAMENT; LYMPHADENOPATHY; MALE; MEDICAL EXAMINATION; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; SOMATOSTATIN BLOOD LEVEL; SOMATOSTATINOMA; SURGICAL TECHNIQUE; TISSUE SECTION; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VOLUME;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; DUODENAL NEOPLASMS; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; SOMATOSTATIN; SOMATOSTATINOMA;

EID: 4644336538     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.704     Document Type: Article

References (16)

1. Davis GB, Berk RN. Intestinal neurofibromas in Von Recklinghausen's disease. Am J Gastroenterol 60: 410-414, 1973.
2. Tanaka S, Yamasaki S, Matsushita H, et a]. Duodenal somatostatinoma: A case report and review of 31 cases with special reference to the relationship between tumor size and metastasis. Pathol Int 50: 146-152, 2000.
3. Krejs GJ, Orci L, Conlon JM, et al. Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med 301: 285-292, 1979.
4. Soga J, Yakuwa Y. Somatostatinoma/inhibitory syndrome: A statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 18: 13-22, 1999.
5. Larsson LI, Hirsch MA, Holst JJ, et al. Pancreatic somatostatinoma. Clinical features and physiological implication. Lancet 1: 666-668, 1977.
6. Kaneko H, Yanaihara N, Ito S, et al. Somatostatinoma of the duodenum. Cancer 44: 2273-2279, 1979.
7. Alumets J, Sundler F, Hakanson R. Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gut. Cell Tissue Res 185: 465-479, 1977.
8. Jackson JA, Raju BU, Fachnie JD, et al. Malignant somatostatinoma presenting with diabetic ketoacidosis. Clin Endocrinol 26: 609-621, 1987.
9. Karasawa Y, Mochizuki T, Kawa S, et al. Insulin and somatostatin releasing islet cell tumor caused hypoglycemia. Intern Med 40: 324-330, 2001.
10. Iguchi H, Kumagai S, Seo IH, Wakasugi H, Hara Y, Abe M. Somatostatin-secreting islet cell tumor (somatostatinoma): suppression of growth hormone (GH) release induced by GH-releasing hormone. J Clin Endoclinol Metab 67: 206-210, 1988.
11. Kouyama K, Totsuka Y. Somatostatinoma and glucose intolerance. Nippon Rinsho 60: 714-718, 2002 (in Japanese).
12. Mao C, Shah A, Hanson DJ, Howard JM. Von Recklinghausen's disease associated with duodenal somatostatinoma: contrast of duodenal versus pancreatic somatostatinomas. J Surg Oncol 59: 67-73, 1995.
13. O'Brien TD, Chejfec G, Prinz RA. Clinical features of duodenal somatostatinomas. Surgery 114: 1144-1147, 1993.
14. Takizawa H, Kaneko H, Koike M, Hirose S, Asakura H. Small duodenal somatostatinoma with high plasma somatostatin level. Am J Gastroenterol 92: 1063-1064, 1997.
15. Angeletti S, Corleto VD, Schillaci O, et al. Use of the somatostatin analogue octreotide to localize and manage somatostatin-producing tumors. Gut 42: 792-794, 1998.
16. Ulfberg J, Tot T, Wilander E. Thirty-year survival with an untreated malignant duodenal somatostatinoma. Endocr Pathol 9: 375-378, 1998.